Abstract
Viral infections are a significant cause of morbidity after allogeneic stem cell transplantation. Modifying intensity of immunosuppression according to immune function may reduce infections. Currently, no routine functional assays to monitor immune function of the new graft exist. The Cylex ImmuKnow assay is a FDA approved test that quantifies cellular immune function by measuring intracellular ATP activity released by PHA-stimulated CD4T cells in blood, and has correlated with solid organ graft outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
